Marathon Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.77M Buy
4,985
+7
+0.1% +$8.26K 1.94% 17
2026
Q2
$5.97M Buy
4,978
+25
+0.5% +$25.5K 2.04% 19
2026
Q1
$4.56M Buy
4,953
+118
+2% +$120K 1.87% 20
2025
Q4
$5.2M Buy
+4,835
New +$4.62M 2.06% 17

Other funds holding LLY

Marathon Wealth Advisors's LLY Position: Q3 2026 in Review

Marathon Wealth Advisors increased its Eli Lilly (LLY) stake by 0.14% in Q3 2026, buying an estimated $8.26K and bringing the position to 4,985 shares worth $5.77M. The position accounts for 1.94% of the portfolio, ranked #17.

Marathon Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.97M in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Marathon Wealth Advisors held 4,985 shares of Eli Lilly worth $5.77M as of Q3 2026.
  • Marathon Wealth Advisors bought 7 Eli Lilly shares in Q3 2026, an estimated $8.26K.
  • Eli Lilly made up 1.94% of Marathon Wealth Advisors's portfolio in Q3 2026, its #17 holding.
  • Marathon Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Marathon Wealth Advisors's Eli Lilly position peaked at $5.97M in Q2 2026.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Marathon Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.